Shownotes
Karen van Gorp was diagnosed with stage IV melanoma in 2013 and survived through a clinical trial for a new class of treatment. She is Chair of Cancer Voices SA and an executive member of Cancer Voices Australia, where she works to strengthen consumer involvement in health technology assessment (HTA). Karen also Co-Chairs the Consumer Advisory Group to Melanoma Patients Australia and serves as Deputy Chair of its Board. In these roles, she focuses on education and organisation to empower con...

